Delivery Order SPE2DB24D8003-SPE2DB25FJUCG
Award Date
3/28/25
Potential Completion Date
3/31/25
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,561.54, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a firm-fixed price delivery order for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive...
This federal contract award, identified as SPE2DB24D8003|SPE2DB24FJTNA, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Dakota Drug, Inc. The contract involves the delivery of pharmaceutical products, specifically the medication VRAYLAR 3 MG CAPSULE 30S, with a ceiling value of $7,338.83. This delivery order contract has a firm fixed-price pricing type and does not utilize any set-aside designations. Dakota Drug, Inc. is a small disadvantaged...
The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price Delivery Order contract worth $6,681.60 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 4563200640 - VRAYLAR 3 MG CAPSULE 30S. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by Dakota Drug, Inc. The contract has an ultimate completion date of January 2, 2024 and does not...
This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $8,587.02 firm fixed-price delivery order is for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The award is not associated with a set-aside program and is scheduled for completion by May 15, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQCC, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,192.94 firm fixed price delivery order is for the provision of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. Dakota Drug, Inc. is a significant supplier for the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $12,402.93 contract is for the delivery of 1.5 mg VRAYLAR capsules. The order has an ultimate completion date of March 12, 2025 and is not associated with a set-aside program. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, allowing the company...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of VRAYLAR 3 MG CAPSULE 30S. The firm-fixed-price contract has a ceiling value of $6,191.88 and a period of performance through February 25, 2025. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA Troop Support Medical's ECAT...
This federal contract award, valued at $1,797.26, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of 4565441401 VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product, under a firm fixed-price delivery order. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,571.81, is for the delivery of Vraylar 1.5 mg capsules. The award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00. This IDC allows the company to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $9,927.91 and a performance period extending to March 11, 2025. The contract was awarded on March 10, 2025 and is a firm fixed-price delivery order contract, without any set-aside designation. Dakota Drug, Inc. is a key supplier for...